Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...
In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...
Lando Norris has become Formula 1 world champion for the first time after finishing third in the Abu Dhabi Grand Prix. The 26-year-old becomes Britain's 11th F1 world champion and is the first McLaren ...
Lando Norris did what he had to do to win the 2025 Formula 1 world championship. Norris, 26, finished third in Sunday’s Abu Dhabi Grand Prix on a two-stop strategy behind race winner Max Verstappen ...
There’s nothing more exciting in Formula 1 than a championship-deciding final race. Think of it as a Game 7 of the NBA Finals that hinges on the final moment of the fourth quarter or a Super Bowl that ...
World-Renowned AI Chip Design Pioneers Anna Goldie and Azalia Mirhoseini Secure $35M Seed Round Led by Sequoia Capital at $750M Final Valuation PALO ALTO, Calif., Dec. 2, 2025 /PRNewswire/ -- ...
After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
The U.S. is in the grips of a botulism outbreak tied to a premium infant formula brand. Dozens of babies have been affected as of November 19. All the reported cases of the paralyzing bacterial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback